The Avera Institute for Human Genetics strongly believes in collaboration. Bringing experts together is the best way to learn and ultimately discover new treatments and therapies. To this end, the Avera Institute for Human Genetics has developed relationships with experts throughout the region, across the nation and around the world.
Avera McKennan Hospital & University Health Center has developed a formal working agreement for further collaboration with Vrije University (VU) in Amsterdam, The Netherlands. Through the agreement, the Avera Institute for Human Genetics is the genetics lab that performs not only all of the genotyping for the Netherlands Twin Register, but also the genotyping for future genetics research in partnership with VU. Together, we work to advance research in genetics and genetic epidemiology. View a list of published papers from Avera's partnership with the Vrije University.
Our team works closely with Dr. Dorret Boomsma, an internationally-recognized leader in twins research, and her team at VU.
The Netherlands Twin Register (NTR) was established in 1987 and designed to provide insight into how genetics and the environment influence individual differences. The NTR examines the contribution of hereditary predisposition to such characteristics as personality, development, disease and risk factors for disease. Since the NTR began, over 7,000 sets of twins between ages 15 and 70 and 28,000 sets of twins between birth and age 15 have registered. Learn more about the Netherlands Twin Register.
University of Nebraska Medical Center
Avera McKennan Hospital & University Health Center has partnered with the University of Nebraska Medical Center Fred & Pamela Buffett Cancer Center to conduct cancer research. This collaboration brings cancer and genetics experts together to develop improved prevention and treatment strategies. Currently, registries have been developed for breast cancer and thyroid tumors and cancer.
The Northern Great Plains Oncology Network establishes a support network for breast cancer care in a four-state region, including South Dakota, Nebraska, North Dakota and Wyoming. The purpose of the program is to collect data, as well as blood and tissue samples, to determine what factors may contribute to breast cancer occurrence and what genes are involved in the successful treatment of breast cancer.
The Thyroid Tumor and Cancer Registry (TCCR) was designed to develop prevention and treatment strategies for thyroid nodules and thyroid cancer. Eligible Avera patients are able to participate in the registry to help advance the research on thyroid tumors and thyroid cancer. Learn more about TCCR.
MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leader in cancer care and research, designated by the National Cancer Institute as a Comprehensive Cancer Center. Through a collaboration on a Grand Opportunity (GO) grant awarded by the National Institutes of Health, the Avera Institute for Human Genetics proudly continues its research relationship with Paul Scheet, PhD, an assistant professor in The University of Texas MD Anderson Cancer Center's Department of Epidemiology.
Dr. Scheet is a respected researcher in the areas of statistical genetics and cancer genomics, as well as other areas. Learn more about Dr. Scheet.